73600 Durability of Icotrokinra (Targeted Oral Peptide) Effects in Adolescents With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the ICONIC-LEAD Study
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB169
DOI: 10.1016/j.jaad.2026.04.697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Jennifer Soung und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Soung, J., Lebwohl, M. G., Hebert, A., Pink, A. E., Shi, Y., Miller-Kassamali, M., Cafone, J., Jiang, J., Li, S., Yang, Y., & Eichenfield, L. (2026). 73600 Durability of Icotrokinra (Targeted Oral Peptide) Effects in Adolescents With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the ICONIC-LEAD Study. Journal of the American Academy of Dermatology, 95(1), AB169. https://doi.org/10.1016/j.jaad.2026.04.697
Vancouver
Soung J, Lebwohl MG, Hebert A, Pink AE, Shi Y, Miller-Kassamali M, et al. 73600 Durability of Icotrokinra (Targeted Oral Peptide) Effects in Adolescents With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the ICONIC-LEAD Study. Journal of the American Academy of Dermatology. 2026;95(1):AB169. doi:10.1016/j.jaad.2026.04.697
BibTeX
@article{Soung2026,
author = {Soung, Jennifer and Lebwohl, Mark G. and Hebert, Adelaide and Pink, Andrew E. and Shi, Yuling and Miller-Kassamali, Megan and Cafone, Joseph and Jiang, Jingzhi and Li, Shu and Yang, Ya-Wen and Eichenfield, Lawrence},
title = {73600 Durability of Icotrokinra (Targeted Oral Peptide) Effects in Adolescents With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the ICONIC-LEAD Study},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB169},
doi = {10.1016/j.jaad.2026.04.697}
}
EUVIMED